medigraphic.com
ISSN 1561-2988 (Print)

2013, Number 1

<< Back Next >>

Rev Cubana Farm 2013; 47 (1)

Cost of the treatment of t elangiectases and varicose veins with foam sclerotherapy in ¨Freyre de Andrade¨hospital in Havana

García FA, Suárez CA, Pérez LEA, Márquez FA

Language: Spanish
References: 19
Page:
PDF size: 320.73 Kb.


ABSTRACT

Objective: To determine the cost of the treatment of varicose veins per patient with the foam sclerotherapy in the angiology and vascular surgery outpatient service of ¨Freyre de Andrade¨ clinical and surgical hospital.
Method: A cost description-type economic assessment. The institutional direct cost of the leg varicose veins treatment with foam sclerotherapy at the outpatient service, using the active principle called 0.5% polidocanol at a dose of 2 ml, was studied. The variables were human resources, disposable materials and drugs. The average cost per patient, the total cost and type of service-depending cost were all estimated.
Results: The total cost per patient was 68.60 Cuban pesos. The mean cost per patient at the classification service was 0.18 Cuban cents (SD 95%=0.12). The mean cost of the treatment service was 50.60 Cuban pesos (95% SD=7.65). There were no significant differences among the different types of varices under treatment.
Conclusions: The institutional direct cost of the treatment of telangiectases and varicose veins by using foam sclerotherapy was comparable. In the short term, the treatment of varices with this method brings lower costs than those of the surgical alternative.


REFERENCES

  1. Hirsch SA, Dillavou E.Options in the management of varicose veins, 2008.J Cardiovasc Surg (Torino). 2008;49(1):19-26.

  2. J. Bergan, l. Pascarella l. Mekenas. Venous disorders: treatment with sclerosant foam. Cardiovasc surg 2006;47:115-24.

  3. Kern P.Sclerotherapy of varicose leg veins. Technique, indications and complications. Int Angiol. 2002;21(2 Suppl 1):40-5.

  4. S Subramonia, TA Lees. The treatment of varicose veins. Ann R Coll Surg Engl 2007; 89: 96100.

  5. Rigby KA, Palfreyman SJ, Beverley C, Michaels JA.Surgery versus sclerotherapy for the treatment of varicose veins. Cochrane Database Syst Rev. 2004; 18 (4):CD004980

  6. Estévez Touzard M, Zacca Peña E y Mc.Cook Martínez J. Angiopatías periféricas en la población senil. Rev Cubana Hig Epidemiol [periódico en la Internet]. 1995 Jun [citado 2008 Jun 13] ; 33(1): 9-10. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-30031995000100005&lng=es&nrm=iso .

  7. McCook Charles- Edouard E, Pons Bravet P y Orbay Araña M de la C. Comportamiento de la Insuficiencia Venosa Crónica en pacientes mayores de 60 años del Consultorio 15. Policlinico Plaza de la Revolución. Enero - Junio de 2002. Centro Nacional de Información de Ciencias Médicas. Facultad Comandante Manuel Fajardo. Universidad Médica de la Habana. 2003 [citado 2008 Jun 13]. Disponible en: http://uvfajardo.sld.cu/Members/emccook/comportamiento-de-la-insuficiencia -venosa-cronica-en-pacientes-geriatricos-de-un-area-de-salud

  8. Slagsvold CE, Stranden E.Venous leg ulcers.Tidsskr Nor Laegeforen. 2005 ;125(7):891-4.

  9. García Fariñas A, Rodríguez Salvá A, De Vos P, Jova Morell R, Bonet Gorbea M, García Roche R, Van der Stuyft P. Costos del subsistema de urgencias en la atención primaria de salud en Cuba, 1999 - 2000. Rev Cubana Salud Pública 2006;32(1): http://bvs.sld.cu/revistas/spu/Vol32_1_06/spusu106.htm

  10. Barroso Utrá IM, García Fariñas A, Rodríguez Salvá A, De Vos P, Bonet Gorbea M, Van der Stuyft P. El ingreso en el hogar y su costo directo en Cuba. Rev Panamericana Salud Pública 2007;21(2/3):85-95.

  11. García Fariñas A, Barroso Utrá I, Rodríguez Salvá A, De Vos P, Van der Stuyft P, Bonet Gorbea M. Costos directos del ingreso en el hogar en Cuba. Rev Cubana Salud Pública 2008; 34(1): http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864 -34662008000100014&lng=es&nrm=iso&tlng=es .

  12. H M Artaza Sanz, M Oliva Pérez. Nueva opción terapéutica para la cirugía de las varices de los miembros inferiores en pacientes ambulatorios. Facultad de Ciencias Médicas Dr. Enrique Cabrera. Hospital General Docente Dr Enrique Cabrera. http://www.ucmh.sld.cu/rhab/articulorev13/cirugvarices.htm

  13. Michaels JA, Campbell WB, Brazier JE, MacIntyre JB, Palfreyman SJ, Ratcliffe J, et al. Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). Health Technol Assess. 2006;10(13):1-196.

  14. Gibson KD, Ferris BL, Pepper D. Foam sclerotherapy for the treatment of superficial venous insufficiency.Surg Clin North Am. 2007;87(5):1285-95.

  15. Bergan J, Cheng V. Foam sclerotherapy for the treatment of varicose veins. Vascular. 2007;15(5):269-72.

  16. Kendler M, Wetzig T, Simon JC. Foam sclerotherapy—a possible option in therapy of varicose veins. J Dtsch Dermatol Ges. 2007 ;5(8):648-54.

  17. Frullini A, Cavezzi A.Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg. 2002;28(1):11-5.

  18. Belcaro G, Nicolaides AN, Ricci A, Dugall M, Errichi BM, Vasdekis S, Christopoulos D. Endovascular sclerotherapy, surgery, and surgery plus sclerotherapy in superficial venous incompetence: a randomized, 10-year follow-up trial—final results. Angiology. 2000;51(7):529-34.

  19. Badri H, Bhattacharya V.A review of current treatment strategies for varicose veins. Recent Patents Cardiovasc Drug Discov. 2008;3(2):126-36.




2020     |     www.medigraphic.com